Iroko, Landsteiner deal

Iroko's Iroko Pharmaceuticals Inc. affiliate granted Landsteiner exclusive rights to develop and commercialize Zorvolex submicron diclofenac in Mexico. Landsteiner will be responsible for regulatory ...